December 9, 2021 Acad, Gov/Utilities Clinical Research/Diagn. Lab Top-10 Life Science Tools

FDA Approves NGS-Based Companion Diagnostic for EGFR Exon20 Insertion Mutant Non-Small Cell Lung Cancer Tumor Tissue

FDA Approves NGS-Based Companion Diagnostic for EGFR Exon20 Insertion Mutant Non-Small Cell Lung Cancer Tumor Tissue CARLSBAD, Calif., Dec. 9, 2021 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has granted premarket approval to Thermo Fisher Scientific’s Oncomine Dx Target Test as a companion diagnostic (CDx) to help identify non-small cell lung cancer (NSCLC) patients... Read more

December 9, 2021 Environ, Ag./Food & Bev Lab Top-10 Product Launch

New Sample Preparation Solution Simplifies Food Safety Testing

The Thermo Scientific QuEChERS portfolio delivers robust, sensitive quantitation in compliance with global regulatory requirements LANGERWEHE, Germany, Dec. 9, 2021 /PRNewswire/ — Food industry, government and contract testing laboratories performing food safety analysis can now benefit from a new portfolio that offers cost-effective, robust Solid-Phase Extraction (SPE) solutions to support food safety workflows and meet regulatory... Read more

December 8, 2021 Lab Top-10 PAI Top-10

Thermo Fisher Scientific Completes Acquisition of PPD, Inc.

Thermo Fisher Scientific Completes Acquisition of PPD, Inc. WALTHAM, Mass., Dec. 8, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has completed its acquisition of PPD, Inc. (Nasdaq: PPD), a leading global provider of clinical research services to the biopharma and biotech industry, for... Read more

December 8, 2021 Lab Top-10 PAI Top-10 Product Launch

PerkinElmer Launches NEXTFLEX Variant-Seq SARS-CoV-2 Kit v2 to Strengthen SARS-CoV-2 Surveillance

New NGS workflow accelerates the detection of SARS-CoV-2 variants including Omicron WALTHAM, Mass.–(BUSINESS WIRE)–Dec. 8, 2021– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced the research use only (RUO) launch of the NEXTFLEX® Variant-Seq™ SARS-CoV-2 Kit v2 to accelerate the detection of SARS-CoV-2 variants. This complete next... Read more

December 8, 2021 Lab Top-10

Bruker Announces $500 Million Private Placement of Senior Notes to Support Strategic Growth Objectives

BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) announced today that it has completed a new private placement of 10-year senior notes in the aggregate principal amount of $500 million to enhance its financial flexibility and fund strategic growth objectives. Gerald Herman, Bruker’s Executive Vice President & Chief Financial Officer, commented “This new debt financing capitalizes... Read more

December 2, 2021 Lab Top-10 Life Science Tools Liq. Handling & Robotics

Bruker Expects its FluoroType® SARS-CoV-2 varID Q PCR Assay to Reliably Detect and Tentatively Differentiate Omicron (B.1.1.529) Variant

Includes robust dual-target SARS-CoV-2 detection and identification of 4 S-gene mutations Reliable detection and even tentative differentiation of Omicron variant expected Validated with the GenoXtract® and GenoXtract ® fleXT extraction system Validated with Bruker’s novel FluoroCycler® XT real-time PCR thermocycler NEHREN, Germany–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced that its established CE-IVD marked FluoroType®... Read more

December 2, 2021 Lab Top-10

Thermo Fisher Scientific and Color Health Launch K-12 ReadyCheckGo COVID-19 Testing Solution for Texas Schools

Thermo Fisher Scientific and Color Health Launch K-12 ReadyCheckGo COVID-19 Testing Solution for Texas Schools WALTHAM, Mass., Dec. 2, 2021 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, and Color Health, a health technology company committed to advancing public health, have launched a significant expansion of the K-12 ReadyCheckGo COVID-19 testing solution in Texas.... Read more

November 30, 2021 Lab Top-10 Product Launch

New High Fidelity CRISPR Cas9 Protein Reduces Off-target Effects for More Precise Genome Editing

New High Fidelity CRISPR Cas9 Protein Reduces Off-target Effects for More Precise Genome Editing Growing CRISPR genome editing portfolio supports researchers on path to future therapeutic applications CARLSBAD, Calif., Nov. 30, 2021 /PRNewswire/ — For research applications requiring highly precise genome editing, including engineering CAR T cells and creating cellular models for disease discovery, the Invitrogen... Read more